Navigation Links
Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
Date:11/20/2008

n a cohort of women who have been heavily, but unsuccessfully, pretreated for metastatic breast cancer," said Dr. Mary Tagliaferri, President and Chief Medical Officer of Bionovo.

Overall compliance with study medication was excellent with 90% of prescribed doses taken. The most common side effects experienced by women in the Phase 1B clinical trial were mild diarrhea and nausea.

"We are encouraged by the results of the Company's second Phase 1 trial in women with advanced breast cancer," said Isaac Cohen, Chairman and CEO of Bionovo. "There are currently over 160,000 women in the United States living with advanced breast cancer who are eagerly awaiting an oral anticancer drug with minimal side effects and the ability to extend life without profoundly diminishing their quality of life. We believe BZL101 may be an important new anticancer agent because its biological selectivity allows the drug to kill cancer cells without affecting normal cells. This will lead to a dramatically lower side effect profile."

Phase 2 Clinical Trial

The Phase 2 clinical trial is currently enrolling 80 women diagnosed with advanced, measurable breast cancer who have received no more than two prior cytotoxic cancer therapies.

The trial is open at the following clinical sites under the directorship of the listed investigators:


    Institution                                    Site Principle Investigator
    California Cancer Care Inc.,
     Greenbrae/San Mateo, California                      Dr. Peter Eisenberg
    Columbia Presbyterian Medical Center,
     New York, New York                                   Dr. Dawn Hershman
    Comprehensive Cancer Center at Desert Regional
     Medical Center, Palm Springs, California             Dr. Gail Leichman
    Duke University, Durham, North Carolina               Dr. Gretchen Kimmick
    Lynn Regional Cancer Center, Boca Raton, Florid
'/>"/>
SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
2. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
3. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
4. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
7. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
8. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
9. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
10. Lytix Presents LTX-109 Anti-Microbial Data at ICAAC
11. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... KANSAS CITY, Kan. , Sept. 18, 2014 ... ), a pet therapeutics company focused on licensing, ... animals, today announced the full exercise of the ... common stock in connection with the company,s previously ... stock.  All of the shares are being offered ...
(Date:9/18/2014)... 2014  LABSCO, the leading specialty sales ... to hospitals, physician office laboratories and alternate ... agreement with Sysmex America.  This agreement is ... the Sysmex XS-1000 i ™, Sysmex pocH-100 ... Automated Hematology Analyzers. The agreement ...
(Date:9/18/2014)...   MacPractice,s MacPractice MD MU version 5.0 ... which designates that the software is capable of supporting ... 2 Meaningful Use measures required to qualify for funding ... MD MU version 5.0 was certified on June 6, ... the National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant ...
Breaking Medicine Technology:Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... Nov. 16, 2010 eMix , a new business venture ... of its cloud-based image sharing technology for studies and ... expansion into the European marketplace, starting in Germany, Austria and Switzerland. ... features are: Automated report delivery – Enables a ...
... 2010 Berger & Montague, P.C. and ... for Lead Plaintiff and the Class in ... announced the following:IN THE UNITED STATES DISTRICT ... HEMISPHERX:BIOPHARMA, INC. LITIGATION:CIVIL ACTION NO.  09-CV-5262-PSD:SUMMARY NOTICE ...
Cached Medicine Technology:At RSNA, eMix to Exhibit EMR Delivery, Other New Features 2Summary Notice of Proposed Settlement, Settlement Fairness Hearing, and Motion for Award of Attorneys' Fees and Reimbursement of Litigation Expenses 2Summary Notice of Proposed Settlement, Settlement Fairness Hearing, and Motion for Award of Attorneys' Fees and Reimbursement of Litigation Expenses 3
(Date:9/18/2014)... Alexandria, VA — The Public ... more communities have joined the growing ranks of those ... The decisions bring the number of governmental public health ... the non-profit organization that administers the national public health ... health of the public by advancing the quality and ...
(Date:9/18/2014)... Steven Reinberg HealthDay Reporter , THURSDAY, ... Ebola outbreak in West Africa is starting to spread faster than ... new cases of the deadly viral infection were reported in just ... more than 5,300, with roughly half of those reported in the ... of deaths now tops 2,600. WHO has estimated that as ...
(Date:9/18/2014)... 18, 2014 Companies in the ... dioxide, selling it to downstream industries in either gas, ... dioxide are food and beverage manufacturers. Food producers use ... vegetables or pizzas. The gas is also used as ... compound to carbonate soft drinks, beer and other beverages. ...
(Date:9/18/2014)... exercise is good for you. But new research from ... an added benefit for cancer patients undergoing chemotherapy. , ... found that combining exercise with chemotherapy shrunk tumors more ... professor in the School of Nursing and director of ... the senior author on the study, which appears in ...
(Date:9/18/2014)... 2014 Qualis Health, one of the ... white paper, “Advancing Primary Care through the Patient-Centered ... , Authors Jeff Hummel, MD, MPH and Peggy ... organizations engaged in the work of becoming a Patient-Centered ... bolster PCMH objectives, such as generating and providing useful ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:Advancing Primary Care Through PCMH and HIT: New White Paper Connects the Dots 2
... scientific study has backed them up by showing that dating, ... they really are. Researchers at the University of Alberta in ... Victoria, carried out the study. ,As a part ... 700 adolescents between 12 to 19 years of age from ...
... the killing last year of an unarmed man on his ... mandatory breathalyzer tests after such shootings. Sean Bell, a 23-year-old ... girlfriend, died in a hail of 50 bullets hours before ... fire on Bells car outside a topless bar. Two ...
... Kerala Tuesday remained glued to their seats in the assembly ... raging fever that has killed 76 people. ... the day. Our only demand is that the government should ... former chief minister Oommen Chandy, now leader of the United ...
... (IIT), Kharagpur, in West Bengal is the top technology ... which held the position last year, a survey ... Data Quest, a technology magazine in India, and International ... IITs have bagged the top seven positions. IIT-Kharagpur climbed ...
... Research from The University of Arizona Sarver Heart Center ... heart disease. Excessive body weight is associated ... left ventricle, the hearts pumping chamber. Known to physicians ... lead to heart failure and rhythm problems. ...
... from Princess Margaret Hospital (PMH) are using a new ... therapy , takes less than an hour and eliminates ... PMH team combined the expertise of surgeons, radiation medicine ... perform its first procedure. It marked the first time ...
Cached Medicine News:Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2Health News:Breathalyzer Tests for Cops Involved in Shootings 2Health News:Kerala Opposition's Unique Protest Over Fever Deaths 2Health News:IIT-Kharagpur the Leading Technology College in India: Survey 2Health News:Interoperative Radiotherapy for Breast Cancer Patients 2
... leads are highly advanced ... to bring ease of ... to you and your ... leads are designed for ...
RV Tracking for 100 % Resynchronization...
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
LOGIQ Book XP provides you the next generation performance in a compact platform....
Medicine Products: